Continuous antagonism by Dkk1 counter activates canonical wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells

Stem Cells and Development

Volumn 21, Issue 1, 2012, Pages 54-66

  Rai, Meena ^a,b   Walthall, Joel M ^a,b   Hu, Jianyong ^a,b   Hatzopoulos, Antonis K ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AXIN; AXIN2; BETA CATENIN; BETA TUBULIN; CD31 ANTIGEN; CERBERUS LIKE 1; DICKKOPF 1 PROTEIN; HEMOGLOBIN; HEMOGLOBIN Y; LUCIFERASE; LYMPHOID ENHANCER FACTOR 1; MEMBRANE PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 6; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MYB; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUBULIN BETA 3; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; WNT PROTEIN; WNT11 PROTEIN; WNT3 PROTEIN; WNT3A PROTEIN; WNT5B PROTEIN; WNT8A PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEMATOPOIESIS; HEMATOPOIETIC CELL; MESODERM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES, FIREFLY; MICE; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84855433908     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0326     Document Type: Article

References (56)

1. Doetschman TC, H Eistetter, M Katz, W Schmidt and R Kemler1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45. (Pubitemid 15029925)
2. Keller G2005). Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19:1129-1155. (Pubitemid 40696181)
3. Sachinidis A, BK Fleischmann, E Kolossov, M Wartenberg, H Sauer and J Hescheler2003). Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 58:278-291. (Pubitemid 36570387)
4. Moretti A, L Caron, A Nakano, JT Lam, A Bernshausen, Y Chen, Y Qyang, L Bu, M Sasaki, et al2006). Multipotent embryonic isl1 + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151-1165. (Pubitemid 44895618)
5. Wu SM, Y Fujiwara, SM Cibulsky, DE Clapham, CL Lien, TM Schultheiss and SH Orkin2006). Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127:1137-1150. (Pubitemid 44914005)
6. Kattman SJ, TL Huber and GM Keller2006). Multipotent flk-1 + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11:723-732. (Pubitemid 44644969)
7. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, et al2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528. (Pubitemid 351733312)
8. Dambrot C, R Passier, D Atsma and CL Mummery2011). Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem J 434:25-35.
9. Chien KR, IJ Domian and KK Parker2008). Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 322:1494-1497.
10. Rao TP and M Kuhl2010). An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 106:1798-1806.
11. Logan CY and R Nusse2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810. (Pubitemid 39488658)
12. MacDonald BT, K Tamai and X He2009). Wnt/betacatenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26.
13. Vincent SD and ME Buckingham2010). How to make a heart: the origin and regulation of cardiac progenitor cells. Curr Top Dev Biol 90:1-41.
14. Gessert S and M Kuhl2010). The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res 107:186-199.
15. Pandur P, M Lasche, LM Eisenberg and M Kuhl2002). Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418:636-641.
16. Ueno S, G Weidinger, T Osugi, AD Kohn, JL Golob, L Pabon, H Reinecke, RT Moon and CE Murry2007). Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A 104:9685-9690. (Pubitemid 47175327)
17. Nakamura T, M Sano, Z Songyang and MD Schneider2003). A Wnt- and beta - catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 100:5834-5839. (Pubitemid 36576894)
18. Qyang Y, S Martin-Puig, M Chiravuri, S Chen, H Xu, L Bu, X Jiang, L Lin, A Granger, et al2007). The renewal and differentiation of Isl1 + cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 1:165-179. (Pubitemid 47224618)
19. Wang H, JB Gilner, VL Bautch, DZ Wang, BJ Wainwright, SL Kirby and C Patterson2007). Wnt2 coordinates the commitment of mesoderm to hematopoietic, endothelial, and cardiac lineages in embryoid bodies. J Biol Chem 282:782-791. (Pubitemid 47076672)
20. Wang H, J Hao and CC Hong2011). Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/ beta-catenin signaling. ACS Chem Biol 6:192-197.
21. Paige SL, T Osugi, OK Afanasiev, L Pabon, H Reinecke and CE Murry2010). Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5:e11134.
22. Weisel KC, HG Kopp, MA Moore, L Studer and T Barberi2010). Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells. Stem Cells Dev 19:745-751.
23. David R, C Brenner, J Stieber, F Schwarz, S Brunner, M Vollmer, E Mentele, J Muller-Hocker, S Kitajima, et al2008). MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol 10:338-345. (Pubitemid 351331021)
24. Schulz H, R Kolde, P Adler, I Aksoy, K Anastassiadis, M Bader, N Billon, H Boeuf, PY Bourillot, et al2009). The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation. PLoS One 4:e6804.
25. Hescheler J, BK Fleischmann, S Lentini, VA Maltsev, J Rohwedel, AM Wobus and K Addicks1997). Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 36:149-162. (Pubitemid 27527340)
26. Beck H, M Semisch, C Culmsee, N Plesnila and AK Hatzopoulos2008). Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am J Pathol 173:77-92. (Pubitemid 351947957)
27. Livak KJ and TD Schmittgen2001). Analysis of relativegene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. (Pubitemid 34164012)
28. Subramaniam A, WK Jones, J Gulick, S Wert, J Neumann and J Robbins1991). Tissue-specific regulation of the alphamyosin heavy chain gene promoter in transgenic mice. J Biol Chem 266:24613-24620. (Pubitemid 21908985)
29. Mountford P, B Zevnik, A Duwel, J Nichols, M Li, C Dani, M Robertson, I Chambers and A Smith1994). Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A 91:4303-4307. (Pubitemid 24143421)
30. Misfeldt AM, SC Boyle, KL Tompkins, VL Bautch, PA Labosky and HS Baldwin2009). Endocardial cells are a distinct endothelial lineage derived from Flk1 + multipotent cardiovascular progenitors. Dev Biol 333:78-89.
31. Kouskoff V, G Lacaud, S Schwantz, HJ Fehling and G Keller2005). Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 102:13170-13175. (Pubitemid 41324997)
32. Okita K, T Ichisaka and S Yamanaka2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317. (Pubitemid 47080336)
33. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324. (Pubitemid 47080337)
34. Zhang J, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson and TJ Kamp2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-e41.
35. Nelson TJ, A Martinez-Fernandez, S Yamada, C Perez- Terzic, Y Ikeda and A Terzic2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416.
36. Boudoulas KD and AK Hatzopoulos2009). Cardiac repair and regeneration: the Rubik s cube of cell therapy for heart disease. Dis Model Mech 2:344-358.
37. Bauwens CL, R Peerani, S Niebruegge, KA Woodhouse, E Kumacheva, M Husain and PW Zandstra2008). Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells 26:2300-2310.
38. Niebruegge S, CL Bauwens, R Peerani, N Thavandiran, S Masse, E Sevaptisidis, K Nanthakumar, K Woodhouse, M Husain, E Kumacheva and PW Zandstra2009). Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygencontrolled bioreactor. Biotechnol Bioeng 102:493-507.
39. Baharvand H, M Azarnia, K Parivar and SK Ashtiani2005). The effect of extracellular matrix on embryonic stem cellderived cardiomyocytes. J Mol Cell Cardiol 38:495-503. (Pubitemid 40331940)
40. Yoshida Y and S Yamanaka2011). iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 50:327-332.
41. Kwon C, KR Cordes and D Srivastava2008). Wnt/betacatenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis. Cell Cycle 7:3815-3818.
42. Eisenberg LM and CA Eisenberg2006). Wnt signal transduction and the formation of the myocardium. Dev Biol 293:305-315.
43. Cohen ED, Y Tian and EE Morrisey2008). Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135:789-798. (Pubitemid 351524132)
44. Huelsken J, R Vogel, V Brinkmann, B Erdmann, C Birchmeier and W Birchmeier2000). Requirement for betacatenin in anterior-posterior axis formation in mice. J Cell Biol 148:567-578.
45. Lindsley RC, JG Gill, M Kyba, TL Murphy and KM Murphy2006). Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development 133:3787-3796. (Pubitemid 44650957)
46. Yamaguchi TP, S Takada, Y Yoshikawa, N Wu and AP McMahon1999). T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev 13: 3185-3190. (Pubitemid 30030440)
47. Chen VC, R Stull, D Joo, X Cheng and G Keller2008). Notch signaling respecifies the hemangioblast to a cardiac fate. Nat Biotechnol 26:1169-1178.
48. Yuasa S, Y Itabashi, U Koshimizu, T Tanaka, K Sugimura, M Kinoshita, F Hattori, S Fukami, T Shimazaki, et al2005). Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 23:607-611. (Pubitemid 41724900)
49. Hao J, MA Daleo, CK Murphy, PB Yu, JN Ho, J Hu, RT Peterson, AK Hatzopoulos and CC Hong2008). Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3:e2904.
50. Blankensteijn JD2000). Mortality and morbidity rates after conventional abdominal aortic aneurysm repair. Semin Interv Cardiol 5:7-13.
51. Barandon L, T Couffinhal, J Ezan, P Dufourcq, P Costet, P Alzieu, L Leroux, C Moreau, D Dare and C Duplaa2003). Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 108:2282-2289. (Pubitemid 37363048)
52. Mirotsou M, Z Zhang, A Deb, L Zhang, M Gnecchi, N Noiseux, H Mu, A Pachori and V Dzau2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104:1643-1648. (Pubitemid 46214644)
53. Alfaro MP, M Pagni, A Vincent, J Atkinson, MF Hill, J Cates, JM Davidson, J Rottman, E Lee and PP Young2008). The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci U S A 105:18366-18371.
54. Kobayashi K, M Luo, Y Zhang, DC Wilkes, G Ge, T Grieskamp, C Yamada, TC Liu, G Huang, et al2009). Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11:46-55.
55. Hahn JY, HJ Cho, JW Bae, HS Yuk, KI Kim, KW Park, BK Koo, IH Chae, CS Shin, et al2006). Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 281:30979-30989.
56. Aisagbonhi O, M Rai, S Ryzhov, N Atria, I Feoktistov and AK Hatzopoulos2011). Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-tomesenchymal transition. Dis Model Mech 4:469-483.